Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Short-term Investments: 2019-2025

Historic Short-term Investments for Burning Rock Biotech (BNR) over the last 4 years, with Sep 2025 value amounting to $419,000.

  • Burning Rock Biotech's Short-term Investments rose 947.50% to $419,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $419,000, marking a year-over-year increase of 947.50%. This contributed to the annual value of $317,000 for FY2024, which is 1764.71% up from last year.
  • Burning Rock Biotech's Short-term Investments amounted to $419,000 in Q3 2025, which was down 81.47% from $2.3 million recorded in Q1 2025.
  • In the past 5 years, Burning Rock Biotech's Short-term Investments ranged from a high of $10.0 million in Q4 2021 and a low of $8,000 during Q1 2024.
  • Over the past 3 years, Burning Rock Biotech's median Short-term Investments value was $368,000 (recorded in 2024), while the average stood at $1.4 million.
  • Per our database at Business Quant, Burning Rock Biotech's Short-term Investments slumped by 99.92% in 2024 and then soared by 28,162.50% in 2025.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Short-term Investments stood at $10.0 million in 2021, then tumbled by 71.28% to $2.9 million in 2022, then slumped by 99.41% to $17,000 in 2023, then spiked by 1,764.71% to $317,000 in 2024, then surged by 947.50% to $419,000 in 2025.
  • Its Short-term Investments was $419,000 in Q3 2025, compared to $2.3 million in Q1 2025 and $317,000 in Q4 2024.